Charles Schwab Investment Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $20 Million - $21 Million	-138,023 Reduced 22.01%	489,030 $73.9 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.93 Million - $3.39 Million	23,228 Added 3.85%	627,053 $91.4 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $4.29 Million - $5.57 Million	38,955 Added 6.9%	603,825 $71.6 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $1.32 Million - $1.97 Million	13,271 Added 2.41%	564,870 $77.8 Million
Q3 2021 Nov 16, 2021	BUY	$98.85 - $138.91 $15.1 Million - $21.2 Million	152,640 Added 38.26%	551,599 $76.6 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $2 Million - $3.19 Million	30,353 Added 8.23%	398,959 $38.7 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $1.55 Million - $2.23 Million	24,268 Added 7.05%	368,606 $25.2 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $198,008 - $298,944	3,043 Added 0.89%	344,338 $29.5 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $1.46 Million - $1.92 Million	24,684 Added 7.8%	341,295 $22.2 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $856,665 - $2.19 Million	29,530 Added 10.29%	316,611 $23.1 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $816,964 - $1.7 Million	29,697 Added 11.54%	287,081 $9.77 Million
Q4 2019 Feb 07, 2020	SELL	$40.86 - $57.65 $198,947 - $280,697	-4,869 Reduced 1.86%	257,384 $14 Million
Q3 2019 Nov 08, 2019	BUY	$37.38 - $49.47 $1.51 Million - $2 Million	40,389 Added 18.2%	262,253 $10.9 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $1.11 Million - $1.87 Million	27,903 Added 14.39%	221,864 $9.72 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $574,033 - $886,159	16,629 Added 9.38%	193,961 $9.98 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $574,859 - $828,956	19,323 Added 12.23%	177,332 $6.56 Million
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $631,338 - $827,922	19,254 Added 13.88%	158,009 $5.93 Million
Q2 2018 Aug 08, 2018	BUY	$23.62 - $42.29 $1.21 Million - $2.16 Million	51,113 Added 58.32%	138,755 $5.48 Million
Q1 2018 May 07, 2018	BUY	$22.49 - $34.56 $1.07 Million - $1.64 Million	47,505 Added 118.36%	87,642 $2.26 Million
Q4 2017 Jan 17, 2018	BUY	$20.44 - $35.56 $38,263 - $66,568	1,872 Added 4.89%	40,137 $1.08 Million
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $900,758 - $1.46 Million	38,265	38,265 $1.43 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account